Berenberg Bank Issues Positive Forecast for Croda International (LON:CRDA) Stock Price

Key Points

• Berenberg Bank has raised its price target for Croda International from GBX 3,100 to GBX 3,300, suggesting a potential upside of 16.69% from the current stock price.
• The company currently holds a Moderate Buy average rating among analysts, with three firms recommending a buy and two assigning hold ratings.
• Insider buying activity has also increased, with insiders acquiring a total of 11,333 shares worth approximately £134,283 over the last three months.

Croda International (LON:CRDA - Get Free Report) had its price objective hoisted by analysts at Berenberg Bank from GBX 3,100 to GBX 3,300 in a report issued on Thursday,Digital Look reports. The firm presently has a "buy" rating on the stock. Berenberg Bank's target price would indicate a potential upside of 16.69% from the stock's previous close.

CRDA has been the topic of several other reports. JPMorgan Chase & Co. raised shares of Croda International to an "overweight" rating in a report on Wednesday, July 30th. Citigroup decreased their price objective on shares of Croda International from GBX 3,300 to GBX 3,050 and set a "neutral" rating on the stock in a research note on Friday, October 3rd. Deutsche Bank Aktiengesellschaft dropped their price objective on Croda International from GBX 3,400 to GBX 3,000 and set a "hold" rating for the company in a research report on Tuesday, July 29th. Finally, Jefferies Financial Group reduced their price target on shares of Croda International from GBX 3,200 to GBX 3,100 and set a "buy" rating on the stock in a research note on Friday. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of GBX 3,137.50.

Croda International Trading Down 2.4%

LON CRDA opened at GBX 2,828 on Thursday. Croda International has a 12 month low of GBX 2,426.77 and a 12 month high of GBX 3,821. The company has a current ratio of 2.72, a quick ratio of 2.25 and a debt-to-equity ratio of 30.90. The stock has a 50 day moving average of GBX 2,611.45 and a 200-day moving average of GBX 2,817.31. The company has a market cap of £3.95 billion, a PE ratio of 1,836.36, a PEG ratio of 1.40 and a beta of 0.74.

Croda International (LON:CRDA - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported GBX 72.20 earnings per share (EPS) for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. On average, equities research analysts anticipate that Croda International will post 181.8307268 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Danuta Gray acquired 1,300 shares of the firm's stock in a transaction dated Friday, August 1st. The stock was purchased at an average price of GBX 2,600 per share, for a total transaction of £33,800. Also, insider Stephen Oxley acquired 3,762 shares of Croda International stock in a transaction dated Tuesday, July 29th. The shares were acquired at an average price of GBX 2,671 per share, with a total value of £100,483.02. Insiders acquired 11,333 shares of company stock worth $29,793,789 over the last three months. Insiders own 0.83% of the company's stock.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.